Table 3.
pRNFL β (95% CI) | p value | GCIPL β (95% CI) | p value | |
---|---|---|---|---|
Vision-related QoL (unadjusted) | 1.03 (0.01 to 2.01) | 0.038 | 1.12 (0.26 to 1.99) | 0.011 |
Vision-related QoL (adjusted for age, sex, and use of DMT) | 0.96 (0.01 to 1.91) | 0.048 | 1.08 (0.28 to 1.87) | 0.008 |
Vision-related QoL (adjusted for age, sex, use of DMT, and MSON | 0.92 (−0.04 to 1.87) | 0.060 | 0.93 (0.15 to 1.71) | 0.020 |
CI: confidence interval; GEE: generalized estimating equations; pRNFL: peripapillary retinal nerve fiber layer; GCIPL: ganglion cell inner plexiform layer; QoL: quality of life; MSON: MS-associated optic neuritis; DMT: disease-modifying treatment.
Adjustments for age, sex, use of DMT, and history of MSON had minimal effect. Data shown as β (95% CI, p value).
All analyses were corrected for inter-eye dependency.